Treatments help patients live with Parkinson's while waiting for cure

06/14/2011 | New York Times (tiered subscription model), The

Patients living with Parkinson's disease have few treatment choices, but many learn to function and slow disease progression in part by following a physical fitness regimen and taking a medication that replaces dopamine in the brain. The Michael J. Fox Foundation for Parkinson's Research is working with the pharmaceutical industry to study biomarkers that help doctors track disease progression and may lead to new drug targets. "A roadblock in developing new drugs has been the inability to predict what will happen over time," said principal investigator Kenneth Marek, a neurologist at Yale University.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL